Clinical Trial Update: Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating fruquintinib combined with tislelizumab and hepatic arterial infusion chemotherapy (HAIC) in advanced colorectal liv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases

Drugs mentioned

• Fruquintinib (fruquintinib)
• HAIC (hepatic artery infusion chemotherapy)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN